Important information about the Novel Coronavirus (COVID-19)

Home
Why Reno CyberKnife
Conditions Treated
Meet Your Team
News
For Patients
Map & Directions
Schedule A Consultation

FOR PATIENTS

GET DIRECTIONS

GET IN TOUCH

(775) 770-7407

Home
Why CyberKnife
Conditions Treated
Clinical Trials
Team
News

Dr. Tay’s interview on the Just the Facts podcast on KCKQ AM

Speak To A Team Member Today!

Being diagnosed with cancer or having a loved one face the disease can be scary. Reno CyberKnife is here to help. Call our office or contact us with the link below to have a member of our team contact you within 24 hours (Monday-Friday).

GET IN TOUCH

645 North Arlington Ave, Suite 120, Reno, NV 89503

Phone: (775) 770-7407

Reno CyberKnife is a service of and located at Saint Mary's Regional Medical Center. This site does not provide medical advice. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

CyberKnife^® is a registered trademark of Accuray Incorporated and is used with permission.
©Copyright 2020 Reno CyberKnife. All Rights Reserved

Videos
Non-Discrimination Policy
Privacy Policy & Terms of Use
Map & Directions
Contact Us
Site Map

Videos
Non-Discrimination Policy
Privacy Policy & Terms of Use
Map & Directions
Contact Us
Site Map

645 North Arlington Ave, Suite 120, Reno, NV 89503

Phone: (775) 770-7407

Reno CyberKnife is a service of and located at Saint Mary's Regional Medical Center. This site does not provide medical advice. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

CyberKnife^® is a registered trademark of Accuray Incorporated and is used with permission.
©Copyright 2020 Reno CyberKnife. All Rights Reserved

Home
Why CyberKnife
Conditions Treated
▼
Clinical Trials
Team
News